DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Genetec Corporation

TSE:4492 Stock Report

Market Cap: JP¥4.6b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Genetec Management

Management criteria checks 2/4

Genetec's CEO is Kenji Ueno, appointed in Jul 1985, has a tenure of 41.17 years. directly owns 45.97% of the company’s shares, worth ¥2.13B. The average tenure of the management team and the board of directors is 3.3 years and 5.3 years respectively.

Key information

Kenji Ueno

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure41.2yrs
CEO ownership46.0%
Management average tenure3.3yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Analysis Article • May 21

With EPS Growth And More, Genetec (TSE:4492) Makes An Interesting Case

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Jul 31

Genetec Corporation (TSE:4492) Might Not Be As Mispriced As It Looks

With a median price-to-earnings (or "P/E") ratio of close to 14x in Japan, you could be forgiven for feeling...
Analysis Article • May 16

Genetec (TSE:4492) Could Easily Take On More Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Apr 19

Take Care Before Diving Into The Deep End On Genetec Corporation (TSE:4492)

There wouldn't be many who think Genetec Corporation's ( TSE:4492 ) price-to-earnings (or "P/E") ratio of 14.3x is...
Analysis Article • Nov 11

Is Genetec (TSE:4492) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Aug 05

Positive Sentiment Still Eludes Genetec Corporation (TSE:4492) Following 34% Share Price Slump

Unfortunately for some shareholders, the Genetec Corporation ( TSE:4492 ) share price has dived 34% in the last thirty...
Analysis Article • Aug 02

Does Genetec (TSE:4492) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • May 23

Genetec Corporation's (TSE:4492) Popularity With Investors Under Threat As Stock Sinks 27%

Genetec Corporation ( TSE:4492 ) shares have had a horrible month, losing 27% after a relatively good period...
Analysis Article • Feb 26

Genetec Corporation (TSE:4492) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected

Genetec Corporation ( TSE:4492 ) shares have continued their recent momentum with a 38% gain in the last month alone...
Analysis Article • Mar 28

Capital Allocation Trends At Genetec (TYO:4492) Aren't Ideal

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • Nov 23

Genetec Corporation (TYO:4492) Has A ROE Of 13%

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

CEO

Kenji Ueno (76 yo)

41.2yrs
Tenure

Mr. Kenji Ueno serves as the President & Representative Director at Genetec Corporation since July 1985 and serves as its Chairman. He serves as Chief Executive Officer at Genetec Corporation.


Leadership Team

NamePositionTenureCompensationOwnership
Kenji Ueno
President41.2yrsno data45.97%
¥ 2.1b
Akihiro Suzuki
Executive VP5.3yrsno data0.38%
¥ 17.6m
Takashi Ogawa
Managing Executive Officerno datano datano data
Tsukasa Suenaga
Senior MEO1.3yrsno data0.061%
¥ 2.8m
Daisuke Ueno
Managing Executive Officer1.3yrsno datano data
3.3yrs
Average Tenure
65.5yo
Average Age

Experienced Management: 4492's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kenji Ueno
President41.2yrsno data45.97%
¥ 2.1b
Akihiro Suzuki
Executive VP5.3yrsno data0.38%
¥ 17.6m
Tsukasa Suenaga
Senior MEO1.3yrsno data0.061%
¥ 2.8m
Daisuke Ueno
Managing Executive Officer1.3yrsno datano data
Masatoshi Hachinohe
Director11.6yrsno data2.6%
¥ 120.4m
Midori Mizutani
Independent Outside Director5.3yrsno data0.0089%
¥ 413.1k
Shunpei Tanaka
Independent Outside Director5.3yrsno data0.0089%
¥ 413.1k
Hiroyoshi Shirakami
Independent Outside Director4.3yrsno data0.0089%
¥ 413.1k
5.3yrs
Average Tenure
65yo
Average Age

Experienced Board: 4492's board of directors are considered experienced (5.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/22 03:17
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genetec Corporation is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kaname FujitaIchiyoshi Research Institute Inc.
Atsushi OhmachiThe Stock Research Center

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide